Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL Trial. Szarek M, Amarenco P, Callahan A, DeMicco D, et al. J Am Coll Cardiol 2020;75:2110-2118.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Szarek M, Amarenco P, Callahan A, DeMicco D, et al. Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL Trial. J Am Coll Cardiol 2020;75:2110-2118.
PMID: 32194196